Lv11
30 积分 2024-10-10 加入
Pharmacokinetic Modeling of the Subcutaneous Absorption of Therapeutic Proteins
2小时前
待确认
Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCB
15天前
已完结
An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager
17天前
已完结
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective
1个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1个月前
已完结
皖公网安备34019202002308
